RIKEN Center for Brain Science, Wako, Saitama 351-0198, Japan; RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan.
RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan; Cellular Informatics Laboratory, RIKEN, Wako, Saitama 351-0198, Japan.
J Biol Chem. 2020 Apr 17;295(16):5257-5277. doi: 10.1074/jbc.RA119.012502. Epub 2020 Mar 6.
β-Glucocerebrosidase (GBA) hydrolyzes glucosylceramide (GlcCer) to generate ceramide. Previously, we demonstrated that lysosomal GBA1 and nonlysosomal GBA2 possess not only GlcCer hydrolase activity, but also transglucosylation activity to transfer the glucose residue from GlcCer to cholesterol to form β-cholesterylglucoside (β-GlcChol) β-GlcChol is a member of sterylglycosides present in diverse species. How GBA1 and GBA2 mediate β-GlcChol metabolism in the brain is unknown. Here, we purified and characterized sterylglycosides from rodent and fish brains. Although glucose is thought to be the sole carbohydrate component of sterylglycosides in vertebrates, structural analysis of rat brain sterylglycosides revealed the presence of galactosylated cholesterol (β-GalChol), in addition to β-GlcChol. Analyses of brain tissues from GBA2-deficient mice and GBA1- and/or GBA2-deficient Japanese rice fish () revealed that GBA1 and GBA2 are responsible for β-GlcChol degradation and formation, respectively, and that both GBA1 and GBA2 are responsible for β-GalChol formation. Liquid chromatography-tandem MS revealed that β-GlcChol and β-GalChol are present throughout development from embryo to adult in the mouse brain. We found that β-GalChol expression depends on galactosylceramide (GalCer), and developmental onset of β-GalChol biosynthesis appeared to be during myelination. We also found that β-GlcChol and β-GalChol are secreted from neurons and glial cells in association with exosomes. enzyme assays confirmed that GBA1 and GBA2 have transgalactosylation activity to transfer the galactose residue from GalCer to cholesterol to form β-GalChol. This is the first report of the existence of β-GalChol in vertebrates and how β-GlcChol and β-GalChol are formed in the brain.
β-葡萄糖脑苷脂酶 (GBA) 将葡萄糖脑苷脂 (GlcCer) 水解为神经酰胺。先前,我们证明溶酶体 GBA1 和非溶酶体 GBA2 不仅具有 GlcCer 水解酶活性,还具有将葡萄糖残基从 GlcCer 转移到胆固醇上以形成 β-胆甾基葡萄糖苷 (β-GlcChol) 的转葡糖基化活性。β-GlcChol 是存在于多种物种中的甾基糖苷的成员。GBA1 和 GBA2 如何在脑中介导 β-GlcChol 代谢尚不清楚。在这里,我们从啮齿动物和鱼类脑中纯化和表征了甾基糖苷。尽管葡萄糖被认为是脊椎动物甾基糖苷中唯一的碳水化合物成分,但对大鼠脑甾基糖苷的结构分析表明,除了 β-GlcChol 之外,还存在半乳糖化胆固醇 (β-GalChol)。对 GBA2 缺陷型小鼠和 GBA1- 和/或 GBA2 缺陷型日本稻鱼 () 脑组织的分析表明,GBA1 和 GBA2 分别负责 β-GlcChol 的降解和形成,而 GBA1 和 GBA2 都负责 β-GalChol 的形成。液相色谱-串联质谱法显示,β-GlcChol 和 β-GalChol 存在于从胚胎到成年期的小鼠大脑发育过程中。我们发现 β-GalChol 的表达依赖于半乳糖脑苷脂 (GalCer),并且 β-GalChol 生物合成的发育起始似乎在髓鞘形成期间。我们还发现 β-GlcChol 和 β-GalChol 与外泌体一起从神经元和神经胶质细胞中分泌出来。酶促分析证实 GBA1 和 GBA2 具有将 GalCer 上的半乳糖残基转移到胆固醇上以形成 β-GalChol 的转半乳糖基化活性。这是首次报道脊椎动物中存在 β-GalChol 以及脑中如何形成 β-GlcChol 和 β-GalChol。